US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

ALLO Allogene Therapeutics Inc

2.74

-0.12 (-4.20%)

Última actualización: 14:17:19

Retrasado por 15 minutos

Ethereum Blockchain Game Pikamoon Raises $3.6m, Final ICO Phase Selling Out Fast

Dubai, United Arab Emirates, July 11th, 2023, Chainwire Pikamoon, an emerging Ethereum blockchain game, has raised $3.6 million in its ... Read more
https://www.valuewalk.com/ethereum-blockchain-game-pikamoon-raises-3-6m-final-ico-phase-selling-out-fast/

Allogene Therapeutics (NASDAQ:ALLO)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Haga Click aquí para más Gráficas Allogene Therapeutics.

Allogene Therapeutics (NASDAQ:ALLO)
Gráfica de Acción Histórica
De May 2023 a May 2024

Haga Click aquí para más Gráficas Allogene Therapeutics.

Noticias sobre Allogene Therapeutics Inc ALLO

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
Lunes 6 de Mayo 2024 (4 días hace) • GlobeNewswire Inc.

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
Viernes 26 de Abril 2024 (2 semanas hace) • GlobeNewswire Inc.

Allogene Therapeutics Announces Q2 Investor Conference Participation
Martes 9 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
Jueves 14 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
Martes 12 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
Martes 5 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
Miércoles 28 de Febrero 2024 (2 meses hace) • GlobeNewswire Inc.

Form 8-K - Current report
Viernes 16 de Febrero 2024 (3 meses hace) • Edgar (US Regulatory)

Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia
Viernes 16 de Febrero 2024 (3 meses hace) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 31 de Enero 2024 (3 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 24 de Enero 2024 (4 meses hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 22 de Enero 2024 (4 meses hace) • Edgar (US Regulatory)

Más de Allogene Therapeutics Inc Artículos de Noticias

Health Care Select Sector

BNP Paribas (QX)

Verizon Communications

Financial Select Sector

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones